Last reviewed · How we verify
Injection of EBV Specific CTLs
Injection of EBV Specific CTLs is a Biologic drug developed by Baylor College of Medicine. It is currently in Phase 1 development.
At a glance
| Generic name | Injection of EBV Specific CTLs |
|---|---|
| Sponsor | Baylor College of Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) (PHASE1)
- Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE (PHASE1)
- EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma (PHASE1)
- Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) (PHASE1)
- Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (PHASE1)
- Cytotoxic T Cells to Prevent Virus Infections (PHASE1)
- LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (PHASE1)
- Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Injection of EBV Specific CTLs CI brief — competitive landscape report
- Injection of EBV Specific CTLs updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI
Frequently asked questions about Injection of EBV Specific CTLs
What is Injection of EBV Specific CTLs?
Injection of EBV Specific CTLs is a Biologic drug developed by Baylor College of Medicine.
Who makes Injection of EBV Specific CTLs?
Injection of EBV Specific CTLs is developed by Baylor College of Medicine (see full Baylor College of Medicine pipeline at /company/baylor-college-of-medicine).
What development phase is Injection of EBV Specific CTLs in?
Injection of EBV Specific CTLs is in Phase 1.